Akebia Therapeutics, Inc. (AKBA) - NASDAQ
From other sites
Company Description
Akebia Therapeutics, Inc. is a biopharmaceutical company, which focuses on development of novel, proprietary therapeutics based on hypoxia-inducible factor biology and the commercialization of these products for patients with kidney disease. Its lead product candidate, AKB-6548, is in a Phase 2b... More
Sector: Healthcare
Industry: Biotechnology
Country: United States